EHR & Claims Data Analytics
Turning Real-World Healthcare Data into Better Clinical and Commercial Decisions
The life sciences industry is generating more data than ever before. Every patient visit, prescription, diagnosis, laboratory result, hospitalization, insurance claim, and treatment outcome contributes to a growing ecosystem of real-world healthcare information. While this data has tremendous potential, organizations often struggle to transform it into meaningful insights that improve research, accelerate clinical development, strengthen regulatory submissions, and support commercial success. Electronic Health Records (EHRs) and healthcare claims databases have become two of the most valuable sources of Real-World Data (RWD). Together, they provide a comprehensive picture of patient populations, disease progression, treatment pathways, healthcare utilization, clinical outcomes, and economic impact across diverse healthcare settings.
As pharmaceutical companies, biotechnology organizations, medical device manufacturers, Contract Research Organizations (CROs), and digital health companies increasingly adopt Real-World Evidence (RWE) strategies and decentralized clinical trials (DCTs), the demand for sophisticated EHR and claims data analytics continues to grow. These datasets are now essential for clinical trial planning, site feasibility, patient recruitment, epidemiological research, health economics and outcomes research (HEOR), market access, payer negotiations, and product lifecycle management.
At BioNetwork Consulting, we help life sciences organizations unlock the full value of patient-level healthcare data by developing tailored EHR and claims data analytics strategies that support better scientific, regulatory, operational, and commercial decisions.
Transforming Healthcare Data into Strategic Insights
Healthcare organizations generate vast amounts of structured and unstructured information every day. Hospitals capture clinical observations through electronic health records, while insurance providers maintain detailed claims databases documenting diagnoses, procedures, prescriptions, reimbursement patterns, and healthcare costs.
Individually, these datasets provide valuable information. When integrated and analyzed together, they offer powerful insights into how diseases are diagnosed, treated, managed, and reimbursed in real-world clinical practice.
Unlike randomized clinical trials, which evaluate therapies under controlled conditions, EHR and claims data reflect routine healthcare delivery across diverse patient populations. This allows organizations to understand how therapies perform outside the clinical trial environment, identify unmet medical needs, evaluate treatment adherence, monitor healthcare resource utilization, and measure long-term outcomes.
Why EHR and Claims Data Matter in Modern Drug Development
Drug development is becoming increasingly data driven. Regulatory agencies, healthcare providers, and payers expect evidence that extends beyond traditional clinical trial results. Organizations must demonstrate not only that therapies are safe and effective, but also that they provide meaningful value in real-world clinical practice.
EHR and claims data analytics play a critical role in meeting these expectations. By analyzing patient-level healthcare data, sponsors can identify appropriate trial populations, estimate disease prevalence, evaluate treatment patterns, forecast enrollment potential, and optimize site selection before studies begin.
During clinical development, these datasets support recruitment planning, protocol refinement, and operational forecasting. Following regulatory approval, they become essential for Real-World Evidence generation, post-market surveillance, comparative effectiveness research, market access, pricing strategy, and Health Economics and Outcomes Research (HEOR).
Our EHR & Claims Data Analytics Services
BioNetwork Consulting provides end-to-end consulting services that help organizations transform healthcare data into actionable business intelligence.
Our consultants begin by understanding each client’s scientific objectives, clinical development strategy, regulatory requirements, and commercial goals. We then design customized analytics approaches that leverage appropriate data sources while maintaining patient privacy, data quality, and regulatory compliance.
Our services include patient population identification, disease prevalence analysis, epidemiological studies, treatment pathway analysis, healthcare utilization assessments, clinical trial feasibility studies, protocol optimization, recruitment forecasting, site selection analytics, outcomes research, comparative effectiveness analysis, payer evidence generation, and market access support.
Supporting Clinical Development with Real-World Data
One of the greatest challenges in clinical research is identifying the right patients, selecting high-performing research sites, and accurately forecasting enrollment timelines. EHR and claims data provide valuable insights that significantly improve these activities.
Historical patient data allows sponsors to estimate the number of eligible participants within specific geographic regions, evaluate referral networks, identify investigator expertise, and assess competing studies that may affect recruitment.
Healthcare claims databases also reveal treatment patterns, disease progression, healthcare utilization, and medication adherence, helping sponsors design more practical clinical protocols that reflect routine medical practice.
These insights improve study feasibility while reducing costly protocol amendments, recruitment delays, and operational inefficiencies.
Frequently Asked Questions
Electronic Health Record (EHR) data contains clinical information collected during patient care, including diagnoses, laboratory results, medications, physician notes, and treatment history. Claims data primarily consists of insurance billing records that capture healthcare services, procedures, diagnoses, prescriptions, and reimbursement information.
Sponsors use these datasets to identify eligible patient populations, evaluate study feasibility, optimize site selection, forecast recruitment, understand disease prevalence, and support decentralized clinical trial planning.
Yes. When analyzed using scientifically robust methodologies, real-world healthcare data can contribute to Real-World Evidence (RWE) used for regulatory submissions, post-market commitments, label expansions, and safety evaluations, depending on applicable regulatory requirements.
Healthcare data helps demonstrate treatment effectiveness, healthcare resource utilization, patient outcomes, and economic value, supporting Health Economics and Outcomes Research (HEOR), payer negotiations, reimbursement submissions, and value dossiers.
We provide strategic consulting across the entire analytics lifecycle, including data strategy, study design, patient population analysis, site feasibility, predictive analytics, Real-World Evidence generation, HEOR support, regulatory compliance, and data governance to help organizations make informed clinical and commercial decisions.